Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Performance of endovenous foam sclerotherapy in the USA for the treatment of venous disorders: ACP/SVM/AVF/SIR quality improvement guidelines. Phlebology 2014 Mar;29(2):76-82



Pubmed ID




Scopus ID

2-s2.0-84905121650   10 Citations


OBJECTIVE: This report summarizes the findings of the consensus panel based on the results of the comprehensive questionnaire of US American College of Phlebology annual congress attendees and results of the systematic meta-analysis of the literature and provides quality improvement guidelines for the use of endovenous foam sclerotherapy (EFS) for the treatment of venous disorders, as well as identifies areas of needed research.

METHODS: Based on the above data, quality improvement guidelines were developed and reviewed by the ten US consensus panel members and approved by their respective societies.

RESULTS: EFS is effective for the treatment of truncal and tributary varicose veins, both as primary treatment and for treatment of recurrence. It may improve the signs and symptoms associated with varicose veins including pain and swelling. EFS is contraindicated in patients who have experienced an allergic reaction to previous treatment with foam or liquid sclerosant, and in patients with acute venous thrombosis events secondary to EFS.

CONCLUSION: These guidelines for the use of EFS in the treatment of venous disorders provide an initial framework for the safe and efficacious use of this therapy, and the impetus to promote the evaluation of the questions remaining regarding the use of EFS through well-designed randomized and cohort studies.

Author List

Rathbun S, Norris A, Morrison N, Gibson K, Raymond-Martimbeau P, Worthington-Kirsch R, Hohenwalter E, Lohr J, McLafferty R, Stoner J


Eric J. Hohenwalter MD Chief, Professor in the Radiology department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Quality Improvement
Randomized Controlled Trials as Topic
Sclerosing Solutions
Societies, Medical
Surveys and Questionnaires
Treatment Outcome
United States
Varicose Veins
Vascular Diseases
Venous Thrombosis
jenkins-FCD Prod-478 d1509cf07a111124a2d122fd3df854cc0b993c00